Argentina Health Minister Highlights 80% Growth in Clinical Trials, 48% of Private R&D

Argentina's Health Minister touted an 80% increase in authorized clinical studies and noted trials now account for over 48% of private R&D investment. The announcement signals a policy push to strengthen national hospital participation in clinical research, though no specific new measures were detailed. This matters as it could attract pharmaceutical investment and improve healthcare infrastructure.